NCT06511037View on ClinicalTrials.gov

PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 13, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2026

Conditions
Gastrointestinal CancerPeritoneal Carcinomatosis
Interventions
DRUG

Pafolacianine (CYTALUX) with intraoperative fluorescent near-infrared (NIR) imaging

Given IV

Trial Locations (1)

92868

RECRUITING

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

Sponsors

Collaborators (1)

On Target Laboratories
All Listed Sponsors
collaborator

On Target Laboratories

UNKNOWN

lead

University of California, Irvine

OTHER

NCT06511037 - PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis | Biotech Hunter | Biotech Hunter